We are a global team of experts and innovators tackling some of the world’s most pressing health challenges. We work with leaders and change makers around the globe to bring health strategies to life. We provide ideas, advice and technical know-how that enable our partners to build a path to lasting change.
With 30 years’ experience in global health, we collaborate with our partners to explore existing evidence, combine expertise, scale up ideas and co-create solutions that accelerate change. This includes collaborating on policy design, managing initiatives, building powerful coalitions and galvanising social movements. Our impact is felt across whole communities, with a focus on women, girls and those who have been marginalised.
As part of MSI Reproductive Choices, all our profits go back into supporting MSI’s own mission of children by choice, not chance.
We believe in a world where everyone can access the high-quality health services they need, without financial burden.
Options is seeking 3 dynamic Research Associates to identify and communicate the evidence base on effective, pro-equity immunization interventions in Gavi 4.0 countries. You will be part of a remote, global team, working collaboratively with the Gavi Secretariat and Options colleagues. Contracting is dependent on Options’ successful completion of the RFP process.
The Research Associates will work collaboratively with the project Team Leader and other Options staff to carry out a retrospective synthesis of evidence on pro-equity immunization interventions to reach zero dose (ZD) children. You will create evidence briefs of proven interventions, and case studies of effective implementation in Gavi countries. Gavi will use these work products to advance its new five-year strategy, which aims to leave no one behind with immunization. The Research Associates will collaborate internally, and externally with Gavi’s Zero Dose working groups, particularly ZD Learn.
Anticipated activities include:
To succeed in this role: